[English] 日本語
Yorodumi- EMDB-10339: Respiratory mucin MUC5B; C-terminal dimerization domain structure -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-10339 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Respiratory mucin MUC5B; C-terminal dimerization domain structure | |||||||||
Map data | Base of the C2 symmetric MUC5B models | |||||||||
Sample |
| |||||||||
Biological species | Homo sapiens (human) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 7.5 Å | |||||||||
Authors | Lockhart-Lockhart MP / Ridley C / Collins RF / Baldock C / Thornton DJ | |||||||||
Funding support | United Kingdom, 1 items
| |||||||||
Citation | Journal: J Biol Chem / Year: 2019 Title: The C-terminal dimerization domain of the respiratory mucin MUC5B functions in mucin stability and intracellular packaging before secretion. Authors: Caroline Ridley / Michael P Lockhart-Cairns / Richard F Collins / Thomas A Jowitt / Durai B Subramani / Mehmet Kesimer / Clair Baldock / David J Thornton / Abstract: Mucin 5B (MUC5B) has an essential role in mucociliary clearance that protects the pulmonary airways. Accordingly, knowledge of MUC5B structure and its interactions with itself and other proteins is ...Mucin 5B (MUC5B) has an essential role in mucociliary clearance that protects the pulmonary airways. Accordingly, knowledge of MUC5B structure and its interactions with itself and other proteins is critical to better understand airway mucus biology and improve the management of lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The role of an N-terminal multimerization domain in the supramolecular organization of MUC5B has been previously described, but less is known about its C-terminal dimerization domain. Here, using cryogenic electron microscopy (cryo-EM) and small-angle X-ray scattering (SAXS) analyses of recombinant disulfide-linked dimeric MUC5B dimerization domain we identified an asymmetric, elongated twisted structure, with a double globular base. We found that the dimerization domain is more resistant to disruption than the multimerization domain suggesting the twisted structure of the dimerization domain confers additional stability to MUC5B polymers. Size-exclusion chromatography-multiangle light scattering (SEC-MALS), SPR-based biophysical analyses and microscale thermophoresis of the dimerization domain disclosed no further assembly, but did reveal reversible, calcium-dependent interactions between the dimerization and multimerization domains that were most active at acidic pH, suggesting that these domains have a role in MUC5B intragranular organization. In summary, our results suggest a role for the C-terminal dimerization domain of MUC5B in compaction of mucin chains during granular packaging via interactions with the N-terminal multimerization domain. Our findings further suggest that the less stable multimerization domain provides a potential target for mucin depolymerization to remove mucus plugs in COPD and other lung pathologies. | |||||||||
History |
|
-Structure visualization
Movie |
Movie viewer |
---|---|
Structure viewer | EM map: SurfViewMolmilJmol/JSmol |
Supplemental images |
-Downloads & links
-EMDB archive
Map data | emd_10339.map.gz | 59.6 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-10339-v30.xml emd-10339.xml | 13.7 KB 13.7 KB | Display Display | EMDB header |
Images | emd_10339.png | 11.2 KB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-10339 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-10339 | HTTPS FTP |
-Related structure data
Related structure data | C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|
-Map
File | Download / File: emd_10339.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Base of the C2 symmetric MUC5B models | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 2.0371 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Sample components
-Entire : Dimeric structure of C-terminal MUC5B base region.
Entire | Name: Dimeric structure of C-terminal MUC5B base region. |
---|---|
Components |
|
-Supramolecule #1: Dimeric structure of C-terminal MUC5B base region.
Supramolecule | Name: Dimeric structure of C-terminal MUC5B base region. / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Homo sapiens (human) / Recombinant cell: HEK293-EBNA / Recombinant plasmid: pCEP-His |
Molecular weight | Experimental: 260 kDa/nm |
-Macromolecule #1: MUC5B
Macromolecule | Name: MUC5B / type: protein_or_peptide / ID: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: EVIYNKTDRA GCHFYAVCNQ HCDID RFQG ACPTSPPPVS SAPLSSPSPA PGCDNAIPLR QVNETWTLEN CTVARCVGDN RVVLLD PKP VANVTCVNKH LPIKVSDPSQ PCDFHYECEC ICSMWGGSHY STFDGTSYTF RGNCTYV LM REIHARFGNL SLYLDNHYCT ...String: EVIYNKTDRA GCHFYAVCNQ HCDID RFQG ACPTSPPPVS SAPLSSPSPA PGCDNAIPLR QVNETWTLEN CTVARCVGDN RVVLLD PKP VANVTCVNKH LPIKVSDPSQ PCDFHYECEC ICSMWGGSHY STFDGTSYTF RGNCTYV LM REIHARFGNL SLYLDNHYCT ASATAAAARC PRALSIHYKS MDIVLTVTMV HGKEEGLI L FDQIPVSSGF SKNGVLVSVL GTTTMRVDIP ALGVSVTFNG QVFQARLPYS LFHNNTEGQ CGTCTNNQRD DCLQRDGTTA ASCKDMAKTW LVPDSRKDGC WAPTGTPPTA SPAAPVSSTP TPTPCPPQP LCDLMLSQVF AECHNLVPPG PFFNACISDH CRGRLEVPCQ SLEAYAELCR A RGVCSDWR GATGGLCDLT CPPTKVYKPC GPIQPATCNS RNQSPQLEGM AEGCFCPEDQ IL FNAHMGI CVQACPCVGP DGFPKFPGER WVSNCQSCVC DEGSVSVQCK PLPCDAQGQP PPC NRPGFV TVTRPRAENP CCPETVCVCN TTTCPQSLPV CPPGQESICT QEEGDCCPTF RCRP QLCSY NGTFYGVGAT FPGALPCHMC TCLSGDTQDP TVQCQEDACN NTTCPQGFEY KRVAG QCCG ECVQTACLTP DGQPVQLNET WVNSHVDNCT VYLCEAEGGV HLLTPQPASC PDVSSC RGS LRKTGCCYSC EEDSCQVRIN TTILWHQGCE TEVNITFCEG SCPGASKYSA EAQAMQH QC TCCQERRVHE ETVPLHCPNG SAILHTYTHV DECGCTPFCV PAPMAPPHTR GFPAQEAT A V |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Concentration | 0.25 mg/mL | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.4 Component:
Details: Buffers were filtered and degassed before use. | |||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: OTHER / Imaging mode: BRIGHT FIELDBright-field microscopy |
Specialist optics | Phase plate: VOLTA PHASE PLATE |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
Image recording | Film or detector model: GATAN K2 SUMMIT (4k x 4k) / Detector mode: COUNTING / Number grids imaged: 1 / Average electron dose: 40.0 e/Å2 |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |
-Image processing
Particle selection | Number selected: 231589 |
---|---|
CTF correction | Software - Name: CTFFIND (ver. 4.1.10) Software - details: Ru nthrough cryoSPARC in exhaustive mode |
Startup model | Type of model: INSILICO MODEL In silico model: Ab initio model was generated using particles from rounds of 2D classification in cryoSPARC. A mask was generated around the stalk of EMD-10264 and used to subtract it from the ...In silico model: Ab initio model was generated using particles from rounds of 2D classification in cryoSPARC. A mask was generated around the stalk of EMD-10264 and used to subtract it from the structure. The subtracted base of the protein was then refined with a local refinement. |
Initial angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. 2.8) |
Final angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. 2.8) |
Final reconstruction | Applied symmetry - Point group: C2 (2 fold cyclic) / Resolution.type: BY AUTHOR / Resolution: 7.5 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC (ver. 2.8) / Number images used: 16590 |